The Sonic Healthcare Ltd (ASX: SHL) share price is in focus today after the company reported strong financial results for the year ended 30 June 2026, with revenue rising 13% to $10.87 billion and underlying net profit up 17% to $621 million.
Image source: Getty Images
What did Sonic Healthcare report?
- Revenue: $10,867 million, up 13% from FY2025
- Underlying EBITDA: $1,933 million, up 11%
- Underlying net profit after tax (NPAT): $621 million, up 17%
- Earnings per share: 125.6 cents, up 14%
- Total dividend: $1.08 per share (final dividend $0.63, franked to 60%)
- Strong organic revenue growth of 5%
What else do investors need to know?
Sonic Healthcare completed several strategic acquisitions during FY2026, including major German provider LADR and Cairo Diagnostics. The integration of these businesses is on track, with over 40% of expected synergies realised in year one for LADR. The company has also continued to sharpen its focus on advanced diagnostics, with standout growth in its genetics and specialist pathology businesses, both in Australia and internationally.
Management is investing in the digital and AI transformation of core systems. Around $30 million per year is earmarked over the next three years to modernise finance, supply chain and HR, supporting future productivity. Meanwhile, a $445 million sale and leaseback of its Brisbane hub laboratory strengthened Sonic Healthcare's balance sheet and capital flexibility.
What's next for Sonic Healthcare?
Looking ahead to FY2027, Sonic Healthcare expects continued organic growth across its major markets, underpinned by demand for personalised and preventative healthcare. The company has provided EBITDA guidance in the range of $1,950 million to $2,030 million (constant currency), excluding costs from its IT transformation program. Some earnings headwinds are anticipated from regulatory changes in Switzerland and a slower ramp-up of profit from its large UK NHS contract.
The group intends to continue progressing US operational improvements, realise further synergy benefits from its recent acquisitions, and optimise costs through automation and strategic procurement.
Sonic Healthcare share price snapshot
It has been a tough 12 months for the Sonic Healthcare share price. During this time, the company's shares have underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of 18%.
